• Home
  • News

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

lexaria bioscience logo

Press Release – New York, New York – May 7, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common stock and warrants for gross proceeds of approximately $2 million. 

The Special Equities Group, a division of Bradley Woods & Co. Ltd., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Jacob Tabman.